- Home
- ESSA vs MDWD Comparison
ESSA vs MDWD Comparison
Compare ESSA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESSA
- MDWD
- Stock Information
- Founded
- ESSA 1916
- MDWD 2000
- Country
- ESSA United States
- MDWD Israel
- Employees
- ESSA N/A
- MDWD N/A
- Industry
- ESSA Banks
- MDWD Medicinal Chemicals and Botanical Products
- Sector
- ESSA Finance
- MDWD Health Care
- Exchange
- ESSA Nasdaq
- MDWD Nasdaq
- Market Cap
- ESSA 195.3M
- MDWD 184.8M
- IPO Year
- ESSA N/A
- MDWD 2014
- Fundamental
- Price
- ESSA $21.23
- MDWD $19.45
- Analyst Decision
- ESSA
- MDWD Strong Buy
- Analyst Count
- ESSA 0
- MDWD 1
- Target Price
- ESSA N/A
- MDWD $25.00
- AVG Volume (30 Days)
- ESSA 43.7K
- MDWD 78.0K
- Earning Date
- ESSA 01-29-2025
- MDWD 03-20-2025
- Dividend Yield
- ESSA 2.86%
- MDWD N/A
- EPS Growth
- ESSA N/A
- MDWD N/A
- EPS
- ESSA 1.74
- MDWD N/A
- Revenue
- ESSA $67,430,000.00
- MDWD $19,720,000.00
- Revenue This Year
- ESSA N/A
- MDWD $10.15
- Revenue Next Year
- ESSA N/A
- MDWD $25.62
- P/E Ratio
- ESSA $11.94
- MDWD N/A
- Revenue Growth
- ESSA N/A
- MDWD N/A
- 52 Week Low
- ESSA $15.29
- MDWD $11.04
- 52 Week High
- ESSA $21.62
- MDWD $24.00
- Technical
- Relative Strength Index (RSI)
- ESSA 58.98
- MDWD 55.03
- Support Level
- ESSA $20.77
- MDWD $19.59
- Resistance Level
- ESSA $21.62
- MDWD $20.62
- Average True Range (ATR)
- ESSA 0.51
- MDWD 0.83
- MACD
- ESSA 0.10
- MDWD 0.02
- Stochastic Oscillator
- ESSA 68.66
- MDWD 54.60
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.